Rudolph P - Search Results

1

repp86: A human protein associated in the progression of mitosis.

Heidebrecht HJ, Adam-Klages S, Szczepanowski M, Pollmann M, Buck F, Endl E, Kruse ML, Rudolph P, Parwaresch R. Heidebrecht HJ, et al. Among authors: rudolph p. Mol Cancer Res. 2003 Feb;1(4):271-9. Mol Cancer Res. 2003. PMID: 12612055

2

Repp86 expression and outcome in patients with neuroblastoma.

Krams M, Heidebrecht HJ, Hero B, Berthold F, Harms D, Parwaresch R, Rudolph P. Krams M, et al. Among authors: rudolph p. J Clin Oncol. 2003 May 1;21(9):1810-8. doi: 10.1200/JCO.2003.05.076. J Clin Oncol. 2003. PMID: 12721258

3

The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen.

Rudolph P, Knüchel R, Endl E, Heidebrecht HJ, Hofstäder F, Parwaresch R. Rudolph P, et al. Mod Pathol. 1998 May;11(5):450-6. Mod Pathol. 1998. PMID: 9619598

4

Immunoenzymatic detection of the new proliferation associated protein p100 by means of a cellular ELISA: specific detection of cells in cell cycle phases S, G2 and M.

Frahm SO, Rudolph P, Dworeck C, Zott B, Heidebrecht H, Steinmann J, Neppert J, Parwaresch R. Frahm SO, et al. Among authors: rudolph p. J Immunol Methods. 1999 Mar 4;223(2):147-53. doi: 10.1016/s0022-1759(98)00217-8. J Immunol Methods. 1999. PMID: 10089093

5

Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.

Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P. Krams M, et al. Among authors: rudolph p. Cancer. 2002 Feb 1;94(3):854-61. Cancer. 2002. PMID: 11857322 Free article.

6

Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.

Rudolph P, Alm P, Olsson H, Heidebrecht HJ, Fernö M, Baldetorp B, Parwaresch R. Rudolph P, et al. Hum Pathol. 2001 Mar;32(3):311-9. doi: 10.1053/hupa.2001.22748. Hum Pathol. 2001. PMID: 11274641

7

Detection of human topoisomerase II alpha in cell lines and tissues: characterization of five novel monoclonal antibodies.

Kellner U, Heidebrecht HJ, Rudolph P, Biersack H, Buck F, Dakowski T, Wacker HH, Domanowski M, Seidel A, Westergaard O, Parwaresch R. Kellner U, et al. Among authors: rudolph p. J Histochem Cytochem. 1997 Feb;45(2):251-63. doi: 10.1177/002215549704500210. J Histochem Cytochem. 1997. PMID: 9016314

8

Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer.

Rudolph P, Kühling H, Alm P, Fernö M, Baldetorp B, Olsson H, Parwaresch R. Rudolph P, et al. Int J Cancer. 2003 Jul 10;105(5):674-80. doi: 10.1002/ijc.11132. Int J Cancer. 2003. PMID: 12740917

9

Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.

Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P. Krams M, et al. Among authors: rudolph p. Am J Pathol. 2003 Mar;162(3):1019-26. doi: 10.1016/S0002-9440(10)63896-5. Am J Pathol. 2003. PMID: 12598334 Free PMC article.

10

Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.

Rudolph P, Alm P, Heidebrecht HJ, Bolte H, Ratjen V, Baldetorp B, Fernö M, Olsson H, Parwaresch R. Rudolph P, et al. J Natl Cancer Inst. 1999 Feb 3;91(3):271-8. doi: 10.1093/jnci/91.3.271. J Natl Cancer Inst. 1999. PMID: 10037106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters